NIH Tackles Irreproducibility

The federal agency speaks out about how to improve the quality of scientific research.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NCI, JOHN CRAWFORDLately the scientific community has been talking about the omnipresent problem of irreproducibility—the failure of researchers to replicate results in the published literature. This week in Nature, National Institutes of Health (NIH) Director Francis Collins and Principal Deputy Director Lawrence Tabak weighed in on this discussion, noting several ways in which the agency hopes to fix the problem.

“Reproducibility is potentially a problem in all scientific disciplines,” the duo wrote. “[T]he checks and balances that once ensured scientific fidelity have been hobbled.”

Collins and Tabak cited poor experimental design and a scientific culture that overvalues provocative statements and high-impact publications as contributors to the problem. Misconduct, they noted, is unlikely to be a main driver. “[F]raudulent papers are vastly outnumbered by the hundreds of thousands published each year in good faith,” they wrote.

Among the suggested solutions is better training for young investigators on experimental design, with an emphasis on “frequently ignored” issues such as “blinding, randomization, replication, sample-size calculation and the effect of sex differences.” Starting later this year, such training will be mandatory for NIH intramural postdoctoral fellows, with corresponding materials ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours